Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) shares traded down 8% during trading on Friday after Citizens Jmp lowered their price target on the stock from $130.00 to $90.00. Citizens Jmp currently has a market outperform rating on the stock. Rocket Lab traded as low as $50.37 and last traded at $50.84. Approximately 23,667,552 shares traded hands during trading, an increase of 2% from the average daily volume of 23,100,502 shares. The stock had previously closed at $55.25.
RKLB has been the topic of several other research reports. KeyCorp lowered their target price on Rocket Lab from $135.00 to $100.00 and set an "overweight" rating on the stock in a research note on Thursday. Raymond James Financial started coverage on Rocket Lab in a research report on Friday, September 11th. They issued an "outperform" rating and a $80.00 target price on the stock. TD Cowen reaffirmed a "buy" rating and set a $90.00 price target on shares of Rocket Lab in a research note on Thursday. KGI Securities upgraded Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 price target for the company in a report on Monday, July 27th. Finally, Cantor Fitzgerald reissued a "mixed" rating and issued a $122.00 price target on shares of Rocket Lab in a research note on Thursday. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $102.05.
Get Our Latest Report on RKLB
Insider Buying and Selling at Rocket Lab
In other news, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the sale, the chief accounting officer owned 26,863 shares of the company's stock, valued at approximately $1,870,470.69. This trade represents a 2.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Clevenger sold 15,051 shares of Rocket Lab stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the sale, the insider directly owned 458,924 shares in the company, valued at $31,954,878.12. The trade was a 3.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 400,749 shares of company stock valued at $26,964,474 in the last three months. Company insiders own 8.40% of the company's stock.
Key Headlines Impacting Rocket Lab
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab continues to benefit from strong underlying demand, including record second-quarter revenue of approximately $234 million, up 62% year over year, and a backlog of roughly $2.4 billion. Its Electron launch, satellite, spacecraft-component and defense businesses remain active while Neutron is delayed. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
- Positive Sentiment: Several analysts remain constructive on the long-term story. TD Cowen reaffirmed a Buy rating with a $90 target, while Citizens JMP maintained Market Outperform despite reducing its target to $90 from $130. Other analysts also continue to see substantial potential if Neutron succeeds. Stay Cool, Says Analyst About Rocket Lab Stock
- Neutral Sentiment: Rocket Lab said Neutron’s inaugural launch is now expected in 2027 rather than the previously targeted fourth quarter of 2026. Management plans additional testing and will establish a launch date afterward. The company says the schedule change reflects a focus on reliability and quality. Rocket Lab Provides Update on Neutron Development and Adjusts Target Launch Timing
- Negative Sentiment: The delay was triggered by manufacturing defects in a carbon-composite forward propellant dome on Neutron’s first-stage tank, following an earlier tank rupture during testing. Because Neutron is central to Rocket Lab’s move into the larger medium-lift launch market, investors are concerned about execution risk, additional cash burn and a later path to positive adjusted EBITDA. Rocket Lab Discusses Neutron Program Update and Manufacturing Challenges
- Negative Sentiment: Wall Street has begun repricing the delay: KeyBanc cut its target to $100 from $135, while Citizens JMP reduced its target to $90 from $130. The stock also remains under pressure from its high valuation, prior equity issuance tied to the pending Iridium acquisition and reported insider selling.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. TB Alternative Assets Ltd. boosted its stake in Rocket Lab by 508.5% in the 3rd quarter. TB Alternative Assets Ltd. now owns 320,703 shares of the rocket manufacturer's stock valued at $22,347,000 after buying an additional 268,000 shares in the last quarter. Cornerstone Enterprises LLC grew its position in Rocket Lab by 74.4% in the third quarter. Cornerstone Enterprises LLC now owns 6,122 shares of the rocket manufacturer's stock valued at $427,000 after acquiring an additional 2,611 shares during the period. NFSG Corp raised its stake in Rocket Lab by 315.0% during the third quarter. NFSG Corp now owns 10,841 shares of the rocket manufacturer's stock worth $755,000 after acquiring an additional 8,229 shares in the last quarter. V Square Quantitative Management LLC raised its stake in Rocket Lab by 207.4% during the third quarter. V Square Quantitative Management LLC now owns 2,327 shares of the rocket manufacturer's stock worth $162,000 after acquiring an additional 1,570 shares in the last quarter. Finally, YANKCOM Partnership acquired a new position in Rocket Lab during the third quarter worth $73,000. Institutional investors own 71.78% of the company's stock.
Rocket Lab Stock Performance
The company has a market capitalization of $30.42 billion, a P/E ratio of -188.29 and a beta of 2.93. The stock has a fifty day simple moving average of $69.50 and a 200-day simple moving average of $84.29. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The firm had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Equities analysts forecast that Rocket Lab Corporation will post -0.20 EPS for the current year.
About Rocket Lab
(
Get Free Report)
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.